Javier Cortés
- Oncology top 0.01%
- HER2/EGFR in Cancer Research 303
- Cancer Treatment and Pharmacology 276
- Cancer Immunotherapy and Biomarkers 83
- Colorectal Cancer Treatments and Studies 53
- Cancer Research top 0.05%
- Breast Cancer Treatment Studies 170
- Cancer Genomics and Diagnostics 59
- Pulmonary and Respiratory Medicine top 0.05%
- Advanced Breast Cancer Therapies 243
-
- Monoclonal and Polyclonal Antibodies Research 70
- Genetics top 0.2%
Javier Cortés
697 papers receiving 28.0k citations
Hit Papers
Peers
Comparison fields: 5 of 170
- Oncology 21.1k
- Cancer Research 8.0k
- Pulmonary and Respiratory Medicine 8.8k
- Radiology, Nuclear Medicine and Imaging 5.3k
- Genetics 1.8k
Countries citing papers authored by Javier Cortés
This map shows the geographic impact of Javier Cortés's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Javier Cortés with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Javier Cortés more than expected).
Fields of papers citing papers by Javier Cortés
This network shows the impact of papers produced by Javier Cortés. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Javier Cortés. The network helps show where Javier Cortés may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Javier Cortés, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Event-free survival by residual cancer burden with pembrolizumab in early-stage TNBC: exploratory analysis from KEYNOTE-522breakdown → | 2024 | 47 |
| 2 | 2024 | 7 | |
| 3 | 2023 | 21 | |
| 4 | 2023 | 1 | |
| 5 | 2023 | 0 | |
| 6 | 2023 | 1 | |
| 7 | 2023 | 11 | |
| 8 | 2023 | 20 | |
| 9 | 2023 | 67 | |
| 10 | 2022 | 1 | |
| 11 | 2021 | 21 | |
| 12 | 2020 | 89 | |
| 13 | 2018 | 17 | |
| 14 | 2018 | 53 | |
| 15 | 2018 | 5 | |
| 16 | 2018 | 55 | |
| 17 | 2018 | 105 | |
| 18 | 2017 | 68 | |
| 19 | Early Adaptation and Acquired Resistance to CDK4/6 Inhibition in Estrogen Receptor–Positive Breast Cancerbreakdown → | 2016 | 511 |
| 20 | 2013 | 36 |
About Javier Cortés
Javier Cortés is a scholar working on Oncology, Cancer Research, Pulmonary and Respiratory Medicine, Radiology, Nuclear Medicine and Imaging and Genetics, having authored 726 papers that have together received 28.6k indexed citations. Recurring topics across this work include HER2/EGFR in Cancer Research (303 papers), Cancer Treatment and Pharmacology (276 papers), Advanced Breast Cancer Therapies (243 papers), Breast Cancer Treatment Studies (170 papers), Cancer Immunotherapy and Biomarkers (83 papers), Monoclonal and Polyclonal Antibodies Research (70 papers), Cancer Genomics and Diagnostics (59 papers) and Colorectal Cancer Treatments and Studies (53 papers). The work is most often cited by research in Oncology (21.1k citations), Cancer Research (8.0k citations), Pulmonary and Respiratory Medicine (8.8k citations), Radiology, Nuclear Medicine and Imaging (5.3k citations) and Genetics (1.8k citations). Javier Cortés has collaborated with scholars based in Spain, United States and United Kingdom. Frequent co-authors include José Baselga, Graham Ross, Nadia Harbeck, Sandra M. Swain, Emma Clark, José Baselga, Sung‐Bae Kim, Fátima Cardoso, Andreas Schneeweiß and Mark Benyunes. Their work appears in journals such as Journal of Clinical Oncology, Cancer Research, Annals of Oncology, ESMO Open and European Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.